Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.61 |
| ▸ | RAB9A | P51151 | 8/20 | 0.61 |
| ▸ | NPC1 | O15118 | 8/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.61 |
| ▸ | PKM | P14618 | 2/20 | 0.61 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 6/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5134195 | 0.89 | NPC1 (0.58) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 | |
| SCHEMBL251370 | 0.81 | NPC1 (0.68) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 | |
| SCHEMBL297468 | 0.81 | RAB9A (0.67) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 | |
| SCHEMBL172216 | 0.78 | NPC1 (1.00) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 | |
| SCHEMBL30561047 | 0.78 | NPC1 (1.00) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 | |
| SCHEMBL30634854 | 0.78 | NPC1 (1.00) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 | |
| SCHEMBL227743 | 0.77 | NPC1 (0.78) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 | |
| Water SCHEMBL9817804 | 0.76 | NPC1 (0.95) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 | |
| SCHEMBL5056429 | 0.76 | RAB9A (0.64) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 | |
| SCHEMBL5058135 | 0.76 | F7 (0.60) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110028730-A1 | CYCLIC COMPOUNDS AND THE USE THEREOF AS LIGHT ABSORBERS, LIGHT EMITTERS, OR COMPLEX LIGANDS | BASF AKTIENGESELLSCHAFT (DE) | 2011-02-03 | — | — | US | disclosed |
| EP-1495025-B1 | CYCLIC COMPOUNDS AND THE USE THEREOF AS LIGHT ABSORBERS OR LIGHT EMITTERS | BASF AG (DE) | 2006-12-20 | — | — | EP | disclosed |
| US-20050167637-A1 | Cyclic compounds and the use thereof as light absorbers, light emitters, or complex ligands | BASF AKTIENGESELLSCHAFT (DE) | 2005-08-04 | — | — | US | disclosed |
| EP-1495025-A1 | CYCLIC COMPOUNDS AND THE USE THEREOF AS LIGHT ABSORBERS, LIGHT EMITTERS, OR COMPLEX LIGANDS | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-12 | — | — | EP | disclosed |
| WO-2003084960-A1 | CYCLIC COMPOUNDS AND THE USE THEREOF AS LIGHT ABSORBERS, LIGHT EMITTERS, OR COMPLEX LIGANDS | BASF AKTIENGESELLSCHAFT (DE) | 2003-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110028730-A1 | CYCLIC COMPOUNDS AND THE USE THEREOF AS LIGHT ABSORBERS, LIGHT EMITTERS, OR COMPLEX LIGANDS | NR2E3, SRD5A1, NR4A1 | ALDH1A1 4062/4885RAB9A 4229/4885NPC1 343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.